Glycated antigen CA50 is one of the tumor markers, which can be elevated in a variety of neoplastic diseases and is commonly used for screening of neoplastic diseases, but it can also be elevated in non-neoplastic diseases, so the specificity is poor, and it is not possible to do qualitative diagnosis.
Glycoantigen CA50 is one of the commonly used tumor markers, often elevated in gastric cancer, breast cancer, pancreatic cancer, ovarian cancer, endometrial cancer and other neoplastic diseases, which can be used for screening of neoplastic diseases, but the specificity is poor, and it is not possible to distinguish the specific type of tumor.
Glycoantigen CA50 can also be elevated in benign diseases such as gastritis, cholecystitis, and gastrointestinal polyps. Although the magnitude of elevation is lower compared with that of neoplastic diseases, it cannot be used to make a qualitative diagnosis, and it needs to be further clarified by other tests.
Glycoantigen CA50 is a tumor marker, commonly used in screening for neoplastic diseases, and other tests are needed to clarify the cause of the disease after an abnormality is detected.